Categories: Joint Venture

Natco’s US partner Breckenridge files ANDA for everolimus

Novartis AG sells these tablets under the Zortress brand name in the US market. The drug is used to prevent organ rejection after a kidney or liver transplant. Zortress generated sales of $ 43.5 million for the 12-month period ending July 2014.

Hyderabad, September 06, 2014 – Breckenridge Pharmaceutical Inc (BPI), the US-based marketing partner of the Hyderabad-based Natco, has filed an abbreviated new drug application (ANDA) for Everolimus 0.25mg, 0.5mg, and 0.75mg tablets.

Novartis AG sells these tablets under the Zortress brand name in the US market. The drug is used to prevent organ rejection after a kidney or liver transplant. Zortress generated sales of $ 43.5 million for the 12-month period ending July 2014.

Natco and Breckenridge Pharmaceutical believe that its Paragraph IV ANDA was filed on the First-to-File date and expects to be the only generic that is entitled to the 180-day exclusivity period, Natco said in a BSE filing. Business Line

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

2 days ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

2 days ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

3 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

3 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

4 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

4 days ago